Literature DB >> 938081

Gentamicin dosage in children.

M Taylor, C Keane.   

Abstract

The results of 49 serum gentamicin assays from children of 2 weeks to 11 years of age are presented. The dose of gentamicin given 8-hourly intramuscularly ranged from 0-7 mg/kg-4-9 mg/kg. Doses of 1-7 mg/kg or less did not give adequate serum concentrations. As a result of these observations it is suggested that an intramuscular dose of 2-5 mg/kg given 8-hourly is suitable for most children in the absence of renal failure, but that adjustment of the dose according to serum gentamicin concentration is necessary.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938081      PMCID: PMC1545990          DOI: 10.1136/adc.51.5.369

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Letter: Serum levels of gentamicin after intravenous bolus injection.

Authors:  R R Bailey; K L Lynn
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

2.  Gentamicin in paediatrics.

Authors:  T A McAllister
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

3.  Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration.

Authors:  J W Paisley; A L Smith; D H Smith
Journal:  Am J Dis Child       Date:  1973-10

4.  The current status of gentamicin for tne neonate and young infant.

Authors:  J D Nelson; G H McCracken
Journal:  Am J Dis Child       Date:  1972-07

5.  Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States.

Authors:  G G Jackson; G Arcieri
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin.

Authors:  G G Jackson; L J Riff
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Gentamicin in pediatrics. II. Treatment of severe urinary-tract infections caused by gram-negative bacilli and of staphylococcal infections.

Authors:  R J Holt; R L Newman
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Clinical and laboratory evaluation of gentamicin in infants and children.

Authors:  H D Riley; T Rubio; W Hinz; A W Nunnery; J Englund
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

9.  Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.

Authors:  P Noone; T M Parsons; J R Pattison; R C Slack; D Garfield-Davies; K Hughes
Journal:  Br Med J       Date:  1974-03-16
  9 in total
  4 in total

Review 1.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

2.  Gentamicin dosage in preterm and term neonates.

Authors:  B M Assael; V Gianni; A Marini; P Peneff; F Sereni
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

3.  A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing.

Authors:  W E Evans; R H Taylor; S Feldman; W R Crom; G Rivera; G C Yee
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

4.  Tobramycin serum level monitoring in young patients with normal renal function.

Authors:  T P Green; B L Mirkin; P K Peterson; A R Sinaiko; N K Ramsay; R F O'Dea
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.